You are here

  • Home
  • Archive
  • Volume 16, Issue 5
  • Lactobacillus rhamnosus GG reduces frequency and severity of abdominal pain compared with placebo in children with irritable bowel syndrome

Article Text

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
Lactobacillus rhamnosus GG reduces frequency and severity of abdominal pain compared with placebo in children with irritable bowel syndrome

https://doi.org/10.1136/ebm1199

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests MAR has received lecture fees and unrestricted scientific grants from Symbiopharm, Danone and Infectopharm – manufacturers/distributors of probiotics.